Autonomix Medical (AMIX) Stock Analysis

What Autonomix Medical does

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Key metrics

ETFs linked to AMIX

Broad-market and Healthcare sector ETFs an investor holding Autonomix Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how AMIX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Autonomix Medical?

Autonomix Medical trades under the ticker AMIX on NASDAQ.

Which exchange is AMIX listed on?

AMIX is listed on NASDAQ.

What sector does Autonomix Medical operate in?

Autonomix Medical is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze AMIX in a portfolio?

PortView shows AMIX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.